SCHEMBL23927529

SCHEMBL23927529

CC(C)(C)OC(=O)N(NC(=O)CC(=O)c1ccnnc1)c1ccc(Br)cc1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 1/20 0.34
MAPT P10636 3/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 1/20 0.33
AAK1 Q2M2I8 1/20 0.32
LMNA P02545 2/20 0.32
HCAR2 Q8TDS4 1/20 0.31
NPC1 O15118 1/20 0.31
RECQL P46063 1/20 0.31
RAB9A P51151 1/20 0.31
CTSS P25774 1/20 0.30
CTSK P43235 1/20 0.30
SSTR4 P31391 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927534 0.89 MT-CO2 (0.36) MAPTALDH1A1SMN1; SMN2LMNAHCAR2
SCHEMBL23927537 0.89 APP (0.32) HCAR2
SCHEMBL23927535 0.88 MAPT (0.34) MAPTALDH1A1HTT
SCHEMBL23927538 0.85 KMT2A (0.33) MAPTALDH1A1SMN1; SMN2KDM4ELMNA
SCHEMBL23927533 0.83 MAPT (0.32) MAPTALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL14740849 0.72 AAK1 (0.39) AAK1
SCHEMBL14740772 0.72 HCAR2 (0.44) ALDH1A1KDM4EHPGDHCAR2
SCHEMBL2138096 0.69 RAB9A (0.45) MAPTALDH1A1KDM4ELMNARAB9A
SCHEMBL7151045 0.69 CNR1 (0.41) ALDH1A1LMNA
SCHEMBL17336825 0.68 RXFP1 (0.35) MAPTALDH1A1SMN1; SMN2KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751095-B1 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF SANFORD BURNHAM MED RES INST (US) 2021-10-27 EP disclosed